We are live on
!
Find out more
SP
Solel Partners Portfolio holdings
AUM
$468M
1-Year Est. Return
2.45%
This Fund
S&P 500
This Quarter
Est. Return
-12.72%
1 Year Est. Return
+2.45%
3 Year Est. Return
+16.25%
5 Year Est. Return
+25.79%
10 Year Est. Return
–
AUM
$543M
AUM Growth
+$80.1M
(+17%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
28.6%
Top 10 Holdings %
Top 10 Hldgs %
67.64%
Holding
33
New
9
Increased
8
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bioceres Crop Solutions
BIOX
|
+$60.8M |
| 2 |
Herbalife
HLF
|
+$30M |
| 3 |
PROG Holdings
PRG
|
+$25.6M |
| 4 |
Amazon
AMZN
|
+$13.9M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$21.3M |
| 2 |
PSPC.U
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
|
+$10.9M |
| 3 |
PG&E
PCG
|
+$3.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.58% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Materials | 11.57% |
| 5 | Financials | 10.58% |
Similar funds
KWS
VCM
LN
SCA
PC
HP
JHC
UC
Solel Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Solel Partners held 33 positions worth $543M, up 17% from $463M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Solel Partners deployed $155M of net new capital in Q2 2022, opening 9 new positions and adding to 8 existing holdings. Its largest new stake was Bioceres Crop Solutions: 4,579,364 shares worth $62.8M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Universal Health Services, an estimated $21.3M trimmed.
- Solel Partners's largest Q2 2022 buy was Bioceres Crop Solutions: 4,579,364 shares worth $62.8M.
- Solel Partners added most to Herbalife in Q2 2022, an estimated $30M increase.
- Solel Partners's biggest Q2 2022 reduction was Universal Health Services, cutting an estimated $21.3M.
- Solel Partners fully exited Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant in Q2 2022, selling an estimated $10.9M.
- Solel Partners's ten largest holdings make up 68% of its $543M portfolio in Q2 2022.
- Solel Partners opened 9 new positions and closed 1 in Q2 2022.
- Solel Partners's portfolio value rose 17% quarter-over-quarter to $543M.
Based on Solel Partners's 13F filing for Q2 2022, filed 15 Aug 2022.